|
Volumn 26, Issue 4, 2001, Pages 303-304
|
Effect of highly active antiretroviral therapy on expression of interleukin-10 and interleukin-12 in HIV-infected patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
INTERLEUKIN 10;
INTERLEUKIN 12;
PROTEINASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DRUG EFFECT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
LONG TERM CARE;
LYMPHOCYTE COUNT;
MACROPHAGE;
MONOCYTE;
MONONUCLEAR CELL;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
STAPHYLOCOCCUS AUREUS;
VIRUS LOAD;
|
EID: 0035309463
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/00126334-200104010-00001 Document Type: Article |
Times cited : (9)
|
References (5)
|